Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.
Secnik Boye K, Matza LS, Oglesby A, Malley K, Kim S, Hayes RP, Brodows R
Health Qual Life Outcomes 2006, 4:80
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Original investigation    
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
Woehl A, Evans M, Tetlow AP, McEwan P
Cardiovascular Diabetology 2008, 7:24 (11 August 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.